anxiety/depressive symptoms
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Informed and written consent. 2.Age =18 years old, male or female. 3.Normal general health, able to understand and comply with study requirements.
Exclusion criteria
Exclusion criteria: 1.Current or previous diagnosis of bipolar disorder, schizophrenia, schizoaffective disorder, neurodevelopmental disorder, neurocognitive disorder according to DMS-5 diagnostic criteria. 2.The patient is currently at significant suicide risk, with a score of = 3 on the HAMD-24 suicide risk item. 3.Special lighting conditions in the working or living environment, including but not limited to basements, dark rooms, tunnels, and studios; or working night shifts for a long time, working across time zones, etc. 4.Use of sedative-hypnotic drugs or other antidepressant, anxiolytic, and antipsychotic drugs within the past 3 months; History of alcoholism, smoking, and other psychoactive substance abuse within the past 3 months. 5.Have used medication to assist sleep in the past 3 months. 6.Current or previous sleep disorders (e.g., restless legs syndrome, etc.). 7.Current or prior suffering from any serious injury, medical or psychological illness that may preclude completion of the trial, including severe cardiovascular, respiratory disease such as stroke; endocrine diseases such as hyperthyroidism; recent surgery; acute or chronic pain; Dementia, traumatic brain injury, etc. 8.Exclude a history of other systemic major diseases. 9.Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sleep quality;Anxiety/Depression level;Biological rhythms; | — |
Secondary
| Measure | Time frame |
|---|---|
| wearable devices to monitor physical activity;demographic information;blood biochemical indicators;genetic;metabolomics;dietary information;gut microbiota;anthropometric indices; | — |
Countries
China
Contacts
Fudan University